Literature DB >> 9471028

Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease.

C E Collins1, D S Rampton, J Rogers, N S Williams.   

Abstract

BACKGROUND AND OBJECTIVES: Mesenteric microvascular thrombosis may be an early pathogenic event in Crohn's disease (CD), and intravascular platelet aggregates have been identified in mucosal biopsies in ulcerative colitis (UC). Activated platelets are involved in thrombogenesis and exhibit inflammatory properties. In active inflammatory bowel disease (IBD) increased numbers of platelet aggregates are detectable in the peripheral circulation. The aim of this study was to test the hypothesis that in IBD, platelet aggregation is triggered in the mesenteric vasculature. PATIENTS AND METHODS: Platelet numbers, platelet aggregate ratios and differential leucocyte counts were compared in mesenteric arterial and venous blood obtained from paired vessels at the time of intestinal resection from 13 patients with inflammatory bowel disease and, as controls, 6 patients with colonic carcinoma or diverticular disease.
RESULTS: In UC and CD, but not in controls, fewer neutrophils were found in blood draining the intestine compared with that supplying it (arteriovenous gradient median 1.0 x 10(9)/l (interquartile range 0.2-1.3) for UC, P < 0.05; 0.8 (0.2-1.5) for CD, P < 0.02; 0.4 (-0.3-1.1) for controls, P = NS). In CD, increased numbers of circulating platelet aggregates were identified in venous samples (platelet aggregate ratio 0.83 (0.71-0.93)) than in paired arterial samples (0.99 (0.95-1.01), P < 0.02) and control venous samples (0.99 (0.93-0.97), P < 0.05). The mesenteric arteriovenous gradient for neutrophils in IBD reflects their migration into the extravascular tissue and lumen of the inflamed intestine. Increased circulating platelet aggregates in the mesenteric venous circulation support the hypothesis that platelet activity is stimulated in the mesenteric microcirculation in CD.

Entities:  

Mesh:

Year:  1997        PMID: 9471028

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  22 in total

1.  Reticulated platelet levels in patients with ulcerative colitis.

Authors:  Hasan Kayahan; Mesut Akarsu; Mehmet Ali Ozcan; Serdal Demir; Halil Ates; Belkis Unsal; Hale Akpinar
Journal:  Int J Colorectal Dis       Date:  2007-06-05       Impact factor: 2.571

2.  Platelet activation and platelet-leukocyte aggregation elicited in experimental colitis are mediated by interleukin-6.

Authors:  Serena L S Yan; Janice Russell; D Neil Granger
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

Review 3.  Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades.

Authors:  Livija Deban; Carmen Correale; Stefania Vetrano; Alberto Malesci; Silvio Danese
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

Review 4.  Multipotent role of platelets in inflammatory bowel diseases: a clinical approach.

Authors:  Evangelos Voudoukis; Konstantinos Karmiris; Ioannis E Koutroubakis
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

Review 5.  Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.

Authors:  Danuta Owczarek; Dorota Cibor; Mikołaj K Głowacki; Tomasz Rodacki; Tomasz Mach
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

6.  Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients.

Authors:  S Danese; J A Katz; S Saibeni; A Papa; A Gasbarrini; M Vecchi; C Fiocchi
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

7.  Apolipoprotein A-IV inhibits experimental colitis.

Authors:  Thorsten Vowinkel; Mikiji Mori; Christian F Krieglstein; Janice Russell; Fumito Saijo; Sulaiman Bharwani; Richard H Turnage; W Sean Davidson; Patrick Tso; D Neil Granger; Theodore J Kalogeris
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 8.  Venous thrombosis and prothrombotic factors in inflammatory bowel disease.

Authors:  Fernando Magro; João-Bruno Soares; Dália Fernandes
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

9.  Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis.

Authors:  Elena Y Senchenkova; Shunsuke Komoto; Janice Russell; Lidiana D Almeida-Paula; Li-Sue Yan; Songlin Zhang; D Neil Granger
Journal:  Am J Pathol       Date:  2013-05-11       Impact factor: 4.307

10.  Evaluation of the mean platelet volume in secondary amyloidosis due to familial Mediterranean fever.

Authors:  Nihal Ozkayar; Serhan Piskinpasa; Fatma Akyel; Fatih Dede; Tolga Yildirim; Didem Turgut; Eyup Koc; Ibrahim C Haznedaroglu
Journal:  Rheumatol Int       Date:  2013-05-15       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.